Department of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, 196, Gondar, Ethiopia.
Malar J. 2012 Jul 20;11:234. doi: 10.1186/1475-2875-11-234.
In Ethiopia, light microscopy is the gold standard for malaria diagnosis although it is not available in most peripheral health facilities. It is time consuming, requires trained personnel and needs careful preparation and application of reagents to ensure quality results. This study was aimed at testing the diagnostic performance of CareStart™ malaria rapid diagnostic test (RDT) with reference to light microscopy for the diagnosis of falciparum and vivax malaria in Ethiopia.
Blood samples were collected from 254 patients suspected to have malaria at Kola Diba Health Center in the late malaria transmission peak season from November 2011 to December 2011. The samples were examined immediately by light microscopy and the RDT (CareStart™ Malaria HRP2/pLDH COMBO Test kit). Statistical analysis was performed using SPSS version 16 and the JavaStat two-way contingency table analysis.
The overall sensitivity and specificity of CareStartTM RDT was found to be 95% (90-97.9%, 95% CI) and 94.2% (90.9-96%, 95% CI), respectively. The sensitivity of the CareStartTM RDT for Plasmodium falciparum or mixed infection was calculated to be 92.9% (82.5-98%, 95%CI) while a sensitivity of 90.9% (74.1-98.4%, 95%CI) was found for non-falciparum species. The specificity for P. falciparum or mixed infections was found to be 95.4% (92.5-96.8%, 95%CI) while it was 97.3% (94.8-98.4%, 95%CI) for non-falciparum species. There was an excellent agreement between the two tests with a kappa value of 0.918.
The CareStartTM RDT test showed good sensitivity and specificity with an excellent agreement to the reference light microscopy. The RDT could therefore be used in place of light microscopy, which in poor set-ups cannot be used routinely.
在埃塞俄比亚,虽然显微镜检查是疟疾诊断的金标准,但大多数外围卫生设施都无法提供。它耗时、需要训练有素的人员,并且需要仔细准备和应用试剂以确保获得高质量的结果。本研究旨在测试 CareStart™疟疾快速诊断检测(RDT)与显微镜检查参考标准相比在诊断埃塞俄比亚间日疟原虫和恶性疟原虫疟疾方面的诊断性能。
2011 年 11 月至 12 月间在疟疾传播高峰期,从 Kola Diba 卫生中心采集了 254 名疑似患有疟疾的患者的血液样本。这些样本立即用显微镜和 RDT(CareStart™疟疾 HRP2/pLDH 组合检测试剂盒)进行检查。使用 SPSS 版本 16 和 JavaStat 双向列联表分析进行统计分析。
CareStartTM RDT 的总体灵敏度和特异性分别为 95%(90-97.9%,95%CI)和 94.2%(90.9-96%,95%CI)。CareStartTM RDT 对恶性疟原虫或混合感染的灵敏度计算为 92.9%(82.5-98%,95%CI),而非恶性疟原虫的灵敏度为 90.9%(74.1-98.4%,95%CI)。对恶性疟原虫或混合感染的特异性为 95.4%(92.5-96.8%,95%CI),而非恶性疟原虫的特异性为 97.3%(94.8-98.4%,95%CI)。两种检测方法之间具有极好的一致性,kappa 值为 0.918。
CareStartTM RDT 检测具有良好的灵敏度和特异性,与参考显微镜检查具有极好的一致性。因此,RDT 可以替代在设备简陋的情况下无法常规使用的显微镜检查。